| 000 | 01676 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517080215.0 | ||
| 264 | 0 | _c20171219 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.7157 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMadan, Babita | |
| 245 | 0 | 0 |
_aNOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition. _h[electronic resource] |
| 260 |
_bOncotarget _cMar 2016 |
||
| 300 |
_a12386-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcyltransferases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAxin Protein _xbiosynthesis |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xbiosynthesis |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 |
_aEsterases _xbiosynthesis |
| 650 | 0 | 4 |
_aFibrosarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aHeterocyclic Compounds, 4 or More Rings _xpharmacology |
| 650 | 0 | 4 | _aHeterografts |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMembrane Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 |
_aWnt Signaling Pathway _xdrug effects |
| 700 | 1 | _aKe, Zhiyuan | |
| 700 | 1 | _aLei, Zheng Deng | |
| 700 | 1 | _aOliver, Frois Ashley | |
| 700 | 1 | _aOshima, Masanobu | |
| 700 | 1 | _aLee, May Ann | |
| 700 | 1 | _aRozen, Steve | |
| 700 | 1 | _aVirshup, David M | |
| 773 | 0 |
_tOncotarget _gvol. 7 _gno. 11 _gp. 12386-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.7157 _zAvailable from publisher's website |
| 999 |
_c25706173 _d25706173 |
||